Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs58975288 | chr2:236192833 | A/G | 3.43E-7 | 171 | 26.58 | 24.7 | 3.07 | KM Plot |
PCPG | rs59024564 | chr1:36922826 | G/A | 8.27E-5 | 176 | 25.4 | 26.62 | 10.3 | KM Plot |
PCPG | rs59108015 | chr18:74524737 | G/C | 7.46E-9 | 174 | 25.6 | 24.83 | 10.17 | KM Plot |
PCPG | rs59145894 | chr16:90116366 | G/A | 7.72E-9 | 177 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs59157557 | chr2:61469410 | C/T | 6.95E-5 | 177 | 23.43 | 30.93 | 10.3 | KM Plot |
PCPG | rs59268342 | chr2:236192637 | C/T | 3.73E-7 | 170 | 27.2 | 24.7 | 3.07 | KM Plot |
PCPG | rs59295315 | chr12:56708576 | G/A | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs59350672 | chr19:19688629 | G/C | 0.00034 | 177 | 25.77 | 26.05 | 23.43 | KM Plot |
PCPG | rs59379575 | chr22:50235976 | C/CA | 0.000197 | 172 | 25.6 | 20.17 | 15.18 | KM Plot |
PCPG | rs594202 | chr5:179417335 | C/T | 0.000243 | 176 | 24.1 | 34.73 | 14.83 | KM Plot |
PCPG | rs59433502 | chr1:36923222 | C/G | 8.73E-5 | 175 | 25.47 | 26.62 | 10.3 | KM Plot |
PCPG | rs595306 | chr17:36997288 | T/C | 4.87E-6 | 173 | 25.17 | 36.33 | 24.53 | KM Plot |
PCPG | rs59549862 | chr1:40519303 | A/G | 0.000336 | 174 | 25.2 | 27.27 | 25.17 | KM Plot |
PCPG | rs59561210 | chr2:242518756 | A/G | 1.24E-10 | 170 | 25.08 | 25.53 | 10.3 | KM Plot |
PCPG | rs59607483 | chr18:44144598 | GT/G | 2.12E-5 | 176 | 25.28 | 25.7 | 11.78 | KM Plot |